Nifty

:

17767.35

Sensex

:

60605.79

-86.70 (-0.49%)
-236.09 (-0.39%)

Login

Nifty
Sensex

:
:

17767.35
60605.79

-86.70 (-0.49%)
-236.09 (-0.39%)

Venus Remedies Ltd.

Pharmaceuticals & Drugs

Rating :

33/99

BSE: 526953 | NSE: VENUSREM

Watchlist

NSE BSE

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

203.18
12.83
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

195.63
N/A
0.44

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.48
9.96
20.83

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-6.38
9.49
8.76

PAT CAGR (%)

10 Years
5 Years
3 Years

-3.36
-
-

P:E (Median)

8 Years
5 Years
3 Years

9.41
4.79
7.48

P:BV (Average)

8 Years
5 Years
3 Years

0.43
0.51
0.76

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.67
7.53
7.26

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var%
Net Sales 109.45 117.44 -6.80% 124.75 192.64 -35.24% 154.93 136.85 13.21% 128.25 102.44 25.20%
Expenses 102.37 103.21 -0.81% 109.58 164.71 -33.47% 136.68 117.49 16.33% 120.95 94.57 27.89%
EBITDA 7.08 14.23 -50.25% 15.17 27.93 -45.69% 18.25 19.36 -5.73% 7.30 7.87 -7.24%
EBIDTM 6.47% 12.11% 12.16% 14.50% 11.78% 14.15% 5.69% 7.68%
Other Income 3.75 1.07 250.47% 1.77 2.96 -40.20% 1.41 1.92 -26.56% 2.48 3.36 -26.19%
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.87 -100.00%
Depreciation 6.97 8.40 -17.02% 8.77 8.46 3.66% 7.57 8.37 -9.56% 7.35 9.18 -19.93%
PBT 3.86 6.90 -44.06% 8.17 22.44 -63.59% 12.09 12.91 -6.35% 2.42 21.74 -88.87%
Tax 1.25 -0.95 - 0.44 -1.69 - 1.00 -1.68 - 0.00 -16.91 -
PAT 2.61 7.85 -66.75% 7.73 24.13 -67.97% 11.09 14.59 -23.99% 2.42 38.65 -93.74%
PATM 2.38% 6.68% 6.20% 12.52% 7.16% 10.66% 1.89% 37.73%
EPS 1.95 5.86 -66.72% 5.77 18.01 -67.96% 8.28 10.89 -23.97% 1.81 28.84 -93.72%

Description Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var%
Net Sales 116.90 124.34 -5.98% 139.89 202.56 -30.94% 143.08 129.81 10.22% 141.94 111.37 27.45%
Expenses 108.80 111.91 -2.78% 126.92 175.26 -27.58% 128.57 112.98 13.80% 136.39 106.88 27.61%
EBITDA 8.10 12.44 -34.89% 12.97 27.30 -52.49% 14.51 16.83 -13.78% 5.54 4.50 23.11%
EBIDTM 6.93% 10.00% 9.27% 13.48% 10.14% 12.96% 3.91% 4.04%
Other Income 3.81 1.22 212.30% 1.79 2.89 -38.06% 1.44 1.95 -26.15% 2.25 3.49 -35.53%
Interest 0.15 0.31 -51.61% 0.00 0.03 -100.00% 0.26 0.14 85.71% 0.00 0.96 -100.00%
Depreciation 7.22 8.64 -16.44% 8.99 8.71 3.21% 7.80 8.62 -9.51% 7.56 9.38 -19.40%
PBT 4.54 4.70 -3.40% 5.77 21.46 -73.11% 7.89 10.02 -21.26% 0.23 18.20 -98.74%
Tax 1.25 -0.95 - 0.44 -1.69 - 1.00 -1.68 - 0.00 -16.91 -
PAT 3.29 5.65 -41.77% 5.33 23.15 -76.98% 6.89 11.70 -41.11% 0.23 35.11 -99.34%
PATM 2.81% 4.54% 3.81% 11.43% 4.82% 9.01% 0.16% 31.53%
EPS 2.46 4.22 -41.71% 3.99 17.32 -76.96% 5.15 8.75 -41.14% 0.17 28.45 -99.40%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 517.38 575.18 514.62 320.23 301.84 355.07 375.45 402.69 451.88 526.06 461.34 Net Sales Growth -5.82% 11.77% 60.70% 6.09% -14.99% -5.43% -6.76% -10.89% -14.10% 14.03% Cost Of Goods Sold 332.50 375.97 336.68 176.81 181.78 205.42 186.69 194.64 213.05 298.96 263.27 Gross Profit 184.88 199.22 177.94 143.42 120.06 149.65 188.76 208.05 238.82 227.10 198.07 GP Margin 35.73% 34.64% 34.58% 44.79% 39.78% 42.15% 50.28% 51.67% 52.85% 43.17% 42.93% Total Expenditure 469.58 506.36 467.76 277.16 267.55 311.51 328.16 323.14 364.94 392.83 342.85 Power & Fuel Cost - 3.78 3.39 3.41 3.50 3.02 3.08 2.90 3.28 3.11 2.86 % Of Sales - 0.66% 0.66% 1.06% 1.16% 0.85% 0.82% 0.72% 0.73% 0.59% 0.62% Employee Cost - 43.75 35.89 33.79 30.26 27.82 25.02 25.02 27.26 25.57 23.24 % Of Sales - 7.61% 6.97% 10.55% 10.03% 7.84% 6.66% 6.21% 6.03% 4.86% 5.04% Manufacturing Exp. - 25.48 20.63 18.35 18.98 34.28 75.01 58.94 73.60 20.75 19.72 % Of Sales - 4.43% 4.01% 5.73% 6.29% 9.65% 19.98% 14.64% 16.29% 3.94% 4.27% General & Admin Exp. - 15.01 13.76 15.22 9.79 11.86 12.20 10.85 14.36 13.81 11.10 % Of Sales - 2.61% 2.67% 4.75% 3.24% 3.34% 3.25% 2.69% 3.18% 2.63% 2.41% Selling & Distn. Exp. - 42.37 57.40 29.59 23.24 29.11 26.17 30.78 33.39 30.64 22.66 % Of Sales - 7.37% 11.15% 9.24% 7.70% 8.20% 6.97% 7.64% 7.39% 5.82% 4.91% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 22.66 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 47.80 68.82 46.86 43.07 34.29 43.56 47.29 79.55 86.94 133.23 118.49 EBITDA Margin 9.24% 11.96% 9.11% 13.45% 11.36% 12.27% 12.60% 19.75% 19.24% 25.33% 25.68% Other Income 9.41 8.43 17.76 3.58 4.51 1.19 3.10 0.67 0.55 0.41 0.39 Interest 0.00 0.00 12.73 13.05 25.15 35.44 35.87 36.74 40.70 29.29 24.45 Depreciation 30.66 32.58 34.28 31.05 32.95 32.73 39.32 40.47 44.74 38.61 31.76 PBT 26.54 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 65.73 62.67 Tax 2.69 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 4.78 5.53 Tax Rate 10.14% -9.67% -32.17% -31.31% 4.07% -13.49% 18.39% 60.13% -123.04% 7.27% 8.82% PAT 23.85 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 60.95 57.15 PAT before Minority Interest 23.85 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 60.95 57.15 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.61% 8.52% 10.55% -2.57% -8.98% -7.49% -5.39% 0.30% 1.01% 11.59% 12.39% PAT Growth -72.01% -9.73% - - - - - -73.63% -92.53% 6.65% EPS 17.80 36.56 40.50 -6.14 -20.23 -19.84 -15.10 0.90 3.40 45.49 42.65

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 541.81 598.65 548.12 339.33 321.89 372.41 400.04 418.27 463.99 541.56 468.64 Net Sales Growth -4.62% 9.22% 61.53% 5.42% -13.57% -6.91% -4.36% -9.85% -14.32% 15.56% Cost Of Goods Sold 339.25 385.45 340.79 174.31 181.95 205.08 227.07 238.51 268.94 300.00 262.26 Gross Profit 202.56 213.20 207.33 165.02 139.94 167.33 172.97 179.77 195.05 241.55 206.38 GP Margin 37.39% 35.61% 37.83% 48.63% 43.47% 44.93% 43.24% 42.98% 42.04% 44.60% 44.04% Total Expenditure 500.68 536.54 494.35 298.52 289.37 332.94 349.32 337.11 374.81 403.33 348.53 Power & Fuel Cost - 4.71 4.58 4.73 4.86 4.29 4.14 4.01 3.80 3.38 3.05 % Of Sales - 0.79% 0.84% 1.39% 1.51% 1.15% 1.03% 0.96% 0.82% 0.62% 0.65% Employee Cost - 52.33 46.02 46.02 42.10 39.31 34.27 32.44 32.36 30.45 27.30 % Of Sales - 8.74% 8.40% 13.56% 13.08% 10.56% 8.57% 7.76% 6.97% 5.62% 5.83% Manufacturing Exp. - 31.57 22.86 20.84 21.01 36.10 42.48 15.70 17.29 22.10 20.61 % Of Sales - 5.27% 4.17% 6.14% 6.53% 9.69% 10.62% 3.75% 3.73% 4.08% 4.40% General & Admin Exp. - 16.91 16.45 17.57 11.85 13.52 13.26 11.97 15.67 14.74 11.82 % Of Sales - 2.82% 3.00% 5.18% 3.68% 3.63% 3.31% 2.86% 3.38% 2.72% 2.52% Selling & Distn. Exp. - 45.56 63.64 35.05 27.60 34.65 28.10 34.48 36.75 32.65 23.50 % Of Sales - 7.61% 11.61% 10.33% 8.57% 9.30% 7.02% 8.24% 7.92% 6.03% 5.01% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.50 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 41.12 62.11 53.77 40.81 32.52 39.47 50.72 81.16 89.18 138.23 120.11 EBITDA Margin 7.59% 10.38% 9.81% 12.03% 10.10% 10.60% 12.68% 19.40% 19.22% 25.52% 25.63% Other Income 9.29 8.31 19.63 5.31 6.09 2.39 4.28 2.01 0.68 0.47 0.44 Interest 0.41 0.48 13.02 13.34 25.41 35.56 36.38 37.98 41.21 29.40 24.63 Depreciation 31.57 33.53 35.28 32.01 33.98 33.83 40.26 41.68 46.00 40.22 33.08 PBT 18.43 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 69.08 62.84 Tax 2.69 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 4.78 5.53 Tax Rate 14.60% -11.86% -27.21% -24.41% 3.87% -11.48% 21.07% 51.57% -94.72% 6.92% 8.80% PAT 15.74 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 64.30 57.31 PAT before Minority Interest 15.74 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 64.30 57.31 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.91% 6.80% 11.27% -2.95% -8.88% -8.24% -4.27% 0.41% 1.11% 11.87% 12.23% PAT Growth -79.18% -34.08% - - - - - -67.05% -91.98% 12.20% EPS 11.75 30.39 46.10 -7.46 -21.32 -22.90 -12.75 1.27 3.85 47.99 42.77

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 449.41 400.18 332.25 340.95 367.99 394.23 444.43 466.24 467.42 392.24 Share Capital 13.37 12.34 12.34 12.34 12.34 12.34 11.44 11.44 11.44 10.54 Total Reserves 436.05 374.09 319.91 328.61 355.65 381.89 432.99 454.79 455.97 376.92 Non-Current Liabilities 45.95 58.81 96.03 136.75 157.89 179.52 212.03 221.50 161.27 147.18 Secured Loans 0.00 0.00 23.92 60.88 86.02 112.69 134.55 150.91 114.28 103.89 Unsecured Loans 38.68 47.52 48.34 55.20 50.84 49.13 56.47 51.34 25.22 25.22 Long Term Provisions 7.95 7.38 6.63 5.32 4.50 4.29 3.79 3.78 3.31 2.91 Current Liabilities 82.61 87.82 215.98 254.46 222.61 193.71 177.59 157.06 207.33 190.06 Trade Payables 49.63 68.36 33.96 33.41 27.19 30.56 23.90 25.76 28.14 17.87 Other Current Liabilities 32.23 18.78 99.99 107.61 76.87 45.70 36.63 13.99 54.12 57.88 Short Term Borrowings 0.00 0.00 81.42 108.92 117.23 115.70 115.09 115.40 110.08 95.68 Short Term Provisions 0.75 0.68 0.61 4.52 1.32 1.76 1.97 1.91 14.99 18.63 Total Liabilities 577.97 546.81 644.26 732.16 748.49 767.46 834.05 844.80 836.02 729.48 Net Block 224.67 244.20 271.47 346.89 369.93 389.38 433.52 425.77 416.09 380.92 Gross Block 578.19 581.73 589.77 674.06 669.01 655.78 660.61 612.50 555.61 481.83 Accumulated Depreciation 353.52 337.53 318.30 327.17 299.08 266.40 227.09 186.73 139.52 100.91 Non Current Assets 313.57 333.08 360.33 478.57 499.96 517.54 575.53 618.72 567.61 500.20 Capital Work in Progress 25.23 25.11 24.63 64.76 64.76 66.25 80.37 78.30 67.80 47.81 Non Current Investment 0.14 0.14 0.14 0.14 0.14 28.74 28.74 28.74 28.74 28.74 Long Term Loans & Adv. 61.96 62.34 64.08 66.78 65.13 33.17 32.90 85.91 54.98 42.74 Other Non Current Assets 1.57 1.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 264.41 213.74 283.94 253.59 248.53 249.93 258.53 226.08 268.41 229.28 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 125.63 119.69 136.44 140.94 135.98 139.69 137.69 140.44 141.46 126.40 Sundry Debtors 30.41 16.44 29.78 31.39 44.15 41.91 53.88 59.37 62.80 53.11 Cash & Bank 49.97 30.24 1.44 1.28 3.64 3.15 3.04 3.52 4.38 6.26 Other Current Assets 58.40 5.70 55.72 5.15 64.77 65.18 63.91 22.76 59.77 43.51 Short Term Loans & Adv. 53.39 41.66 60.56 74.83 59.93 65.18 63.91 22.76 59.77 43.51 Net Current Assets 181.80 125.92 67.96 -0.87 25.93 56.22 80.94 69.02 61.08 39.21 Total Assets 577.98 546.82 644.27 732.16 748.49 767.47 834.06 844.80 836.02 729.48

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 440.45 400.28 323.37 332.52 361.91 388.67 437.62 456.68 461.61 379.13 Share Capital 13.37 12.34 12.34 12.34 12.34 12.34 11.44 11.44 11.44 10.54 Total Reserves 427.08 374.19 311.03 320.18 349.57 376.33 426.18 445.24 450.17 363.81 Non-Current Liabilities 45.95 58.12 95.82 136.68 158.47 179.52 212.05 221.55 161.75 147.18 Secured Loans 0.00 0.09 24.19 61.29 86.60 112.69 134.57 150.95 114.76 103.89 Unsecured Loans 38.68 46.74 47.87 54.73 50.84 49.13 56.47 51.34 25.22 25.22 Long Term Provisions 7.95 7.38 6.63 5.32 4.50 4.29 3.79 3.78 3.31 2.91 Current Liabilities 92.74 97.45 224.58 263.62 230.38 196.81 193.14 162.83 210.99 191.25 Trade Payables 54.29 71.36 36.70 36.00 29.33 29.73 25.14 29.56 31.22 18.76 Other Current Liabilities 33.64 21.10 101.70 110.30 78.47 46.16 42.71 15.96 54.70 58.18 Short Term Borrowings 4.06 4.30 85.58 112.80 121.26 119.16 123.32 115.40 110.08 95.68 Short Term Provisions 0.75 0.68 0.61 4.52 1.32 1.76 1.97 1.91 14.99 18.63 Total Liabilities 579.14 555.85 643.77 732.82 750.76 765.00 842.81 841.06 834.35 717.56 Net Block 240.94 261.68 289.37 364.45 389.20 406.18 452.48 443.65 439.46 401.42 Gross Block 612.50 616.32 623.96 707.02 702.77 686.50 679.57 641.12 587.38 511.00 Accumulated Depreciation 371.57 354.63 334.59 342.57 313.57 280.32 227.09 197.47 147.93 109.58 Non Current Assets 301.10 321.82 349.77 467.39 490.50 505.60 565.75 607.85 562.24 491.97 Capital Work in Progress 25.23 25.11 24.63 64.76 64.76 66.25 80.37 78.30 67.80 47.81 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 34.93 35.03 35.77 38.18 36.53 33.17 32.90 85.91 54.98 42.74 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 278.04 234.03 294.00 265.43 260.27 259.41 277.07 233.21 272.11 225.58 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 125.64 119.99 141.12 142.73 138.17 140.60 143.29 142.87 142.26 128.03 Sundry Debtors 38.60 32.04 30.69 38.04 47.27 47.29 61.59 63.22 64.99 47.11 Cash & Bank 50.40 31.42 2.13 2.81 3.98 3.56 7.07 3.62 4.41 6.36 Other Current Assets 63.40 5.70 55.72 5.15 70.84 67.96 65.12 23.51 60.47 44.08 Short Term Loans & Adv. 58.39 44.88 64.34 76.70 66.00 67.96 65.12 23.51 60.47 44.08 Net Current Assets 185.30 136.59 69.43 1.81 29.88 62.59 83.93 70.38 61.12 34.33 Total Assets 579.14 555.85 643.77 732.82 750.77 765.01 842.82 841.06 834.35 717.55

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 40.90 132.34 77.75 43.65 51.58 61.77 41.91 66.76 52.56 50.66 PBT 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 65.73 62.67 Adjustment 24.83 21.59 40.39 59.20 64.73 69.30 53.72 81.90 35.95 39.38 Changes in Working Capital -28.60 69.69 20.37 3.75 10.27 17.27 -14.82 -17.18 -49.12 -51.39 Cash after chg. in Working capital 40.90 108.89 63.31 43.65 51.58 61.77 41.91 66.76 52.56 50.66 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 23.44 14.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -16.65 55.98 -4.64 -11.27 -11.48 -18.06 3.20 -67.15 -93.75 -102.47 Net Fixed Assets 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 -93.77 -101.63 Net Investments 0.00 0.00 0.00 0.00 28.60 0.00 0.00 0.00 0.00 0.00 Others -20.07 48.42 -129.06 -6.22 -28.34 -37.01 53.38 0.24 0.02 -0.84 Cash from Financing Activity -9.13 -161.88 -72.35 -34.74 -39.61 -43.60 -45.59 -0.47 39.31 55.15 Net Cash Inflow / Outflow 15.12 26.45 0.76 -2.36 0.49 0.11 -0.48 -0.86 -1.88 3.35 Opening Cash & Equivalents 27.70 0.00 0.50 3.64 3.15 3.04 3.52 4.38 6.26 2.91 Closing Cash & Equivalent 42.83 26.45 1.26 1.28 3.64 3.15 3.04 3.52 4.38 6.26

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 41.00 131.84 77.60 45.33 31.19 58.93 46.88 67.80 52.65 52.15 PBT 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 69.08 62.84 Adjustment 26.33 21.89 41.56 60.72 66.24 70.61 56.41 83.56 37.21 40.72 Changes in Working Capital -21.74 61.39 20.82 5.37 -7.52 9.96 -13.04 -18.40 -53.65 -51.41 Cash after chg. in Working capital 41.00 108.39 63.16 45.33 31.19 58.93 46.88 67.80 52.65 52.15 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 23.44 14.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -16.63 56.49 -4.75 -11.33 -11.48 -18.32 2.92 -67.18 -94.66 -103.89 Net Fixed Assets 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 -93.77 -101.63 Net Investments 0.00 0.00 0.00 0.00 28.60 0.00 0.00 0.00 0.00 0.00 Others -20.05 48.93 -129.17 -6.28 -28.34 -37.27 53.10 0.21 -0.89 -2.26 Cash from Financing Activity -9.48 -162.24 -73.00 -35.17 -39.23 -44.13 -46.35 -1.42 40.06 55.15 Net Cash Inflow / Outflow 14.90 26.09 -0.15 -1.17 -19.52 -3.51 3.46 -0.79 -1.95 3.41 Opening Cash & Equivalents 28.88 1.94 2.03 3.98 0.00 7.07 3.62 4.41 6.36 2.95 Closing Cash & Equivalent 43.26 28.88 1.94 2.81 -19.52 3.56 7.07 3.62 4.41 6.36

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 336.21 313.10 269.21 276.25 298.16 319.42 388.42 407.48 408.51 367.54 ROA 8.71% 9.11% -1.20% -3.66% -3.51% -2.53% 0.14% 0.54% 7.79% 8.68% ROE 11.72% 15.10% -2.44% -7.65% -6.98% -4.83% 0.26% 0.97% 14.26% 16.38% ROCE 9.55% 10.80% 1.15% -0.48% 1.75% 1.50% 5.11% 5.55% 13.40% 14.49% Fixed Asset Turnover 0.99 0.88 0.51 0.45 0.54 0.57 0.63 0.77 1.02 1.04 Receivable days 14.87 16.39 34.86 45.68 44.23 46.56 51.33 49.34 40.15 38.45 Inventory Days 77.84 90.83 158.08 167.43 141.69 134.83 126.05 113.85 92.77 87.83 Payable days 57.28 55.46 42.49 37.63 31.43 27.90 25.33 24.89 20.07 14.84 Cash Conversion Cycle 35.43 51.76 150.45 175.48 154.49 153.50 152.04 138.30 112.85 111.44 Total Debt/Equity 0.09 0.12 0.65 0.86 0.82 0.78 0.74 0.68 0.62 0.70 Interest Cover 0.00 4.23 0.52 -0.12 0.34 0.31 1.08 1.05 3.24 3.56

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 329.50 313.18 262.01 269.42 293.23 314.92 382.47 399.13 403.43 355.10 ROA 7.18% 10.30% -1.45% -3.85% -4.05% -2.12% 0.20% 0.62% 8.29% 8.87% ROE 9.85% 17.40% -3.05% -8.23% -8.18% -4.13% 0.38% 1.12% 15.38% 17.04% ROCE 7.89% 12.37% 0.90% -0.67% 1.17% 2.00% 5.35% 5.74% 14.06% 14.85% Fixed Asset Turnover 0.97 0.88 0.51 0.46 0.54 0.59 0.63 0.76 0.99 1.00 Receivable days 21.54 20.89 36.97 48.37 46.34 49.67 54.45 50.42 37.72 33.88 Inventory Days 74.88 86.94 152.66 159.26 136.61 129.51 124.86 112.15 90.94 87.34 Payable days 59.49 57.86 42.82 37.91 30.30 26.74 26.74 27.25 21.28 15.09 Cash Conversion Cycle 36.93 49.96 146.80 169.72 152.65 152.44 152.57 135.32 107.37 106.14 Total Debt/Equity 0.10 0.13 0.68 0.90 0.85 0.80 0.77 0.70 0.63 0.72 Interest Cover 76.69 4.73 0.40 -0.17 0.23 0.41 1.09 1.06 3.35 3.55

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Venus Remedies bags Great Place To Work Certified in India
2nd Feb 2023, 16:57 PM

This is the fifth time and for the second consecutive year that the company has received this coveted recognition
Read More
Venus Remedies - Quarterly Results
12th Nov 2022, 19:51 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback